Miravant Medical Technologies Inc.
MRVT · OTC
9/30/2005 | 6/30/2005 | 3/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.03 | -0.18 | 0.34 |
| FCF Yield | -24.86% | -17.45% | -8.96% | -4.99% |
| EV / EBITDA | -6.30 | -4.78 | -11.41 | -14.85 |
| Quality | ||||
| ROIC | 83.30% | 67.05% | 111.48% | 42.48% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.99 | 0.65 | 0.75 | 0.56 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -8.26% | -17.88% | -53.46% | 41.66% |
| Safety | ||||
| Net Debt / EBITDA | -1.37 | -0.44 | -1.76 | -1.63 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |